Walking Fish Therapeutics Revenue and Competitors

Location

$73M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Walking Fish Therapeutics's estimated annual revenue is currently $4M per year.(i)
  • Walking Fish Therapeutics's estimated revenue per employee is $77,500
  • Walking Fish Therapeutics's total funding is $73M.

Employee Data

  • Walking Fish Therapeutics has 51 Employees.(i)
  • Walking Fish Therapeutics grew their employee count by 24% last year.

Walking Fish Therapeutics's People

NameTitleEmail/Phone
1
Founder and CEOReveal Email/Phone
2
Scientist II, In Vivo BiologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Walking Fish Therapeutics?

Walking Fish has created a broad B cell platform for oncology, regenerative medicine, autoimmune disease, and recombinant antibody production. As a leader in B cell engineering, Walking Fish has made critical advances in engineering technologies and has a deep understanding about B cell biology. The WFT team includes experienced researchers excited about our new approach to the treatment of severe diseases.

keywords:N/A

$73M

Total Funding

51

Number of Employees

$4M

Revenue (est)

24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Walking Fish Therapeutics News

2022-04-13 - Cell therapy developer Be Bio hauls in $130M for pipeline in rare ...

The first cell therapies were made from T cells harvested from a ... South San Francisco-based Walking Fish Therapeutics launched last...

2022-02-22 - Walking Fish Therapeutics Closes $73 Million Series A Financing

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Walking Fish Therapeutics, a leader in B cell therapeutics, today announced the completion of...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.1M5216%N/A
#2
$11.5M526%N/A
#3
$4.2M544%$166.7M
#4
$8.7M568%N/A
#5
$11.6M57-10%N/A